Saroja Pharma Industries India Ltd

NSE: SAROJA · Chemicals & Petrochemicals · 8 announcements

Share price: ₹40.80
Market cap: ₹16.40 Cr
Revenue (annual): ₹70.13 Cr
Net profit (annual): ₹1.62 Cr
P/E (TTM): 10.1×Sector 37.2×
Promoter holding: 73.02%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Board Meeting Outcome 2 Other Announcement 1 Management Change 1 Fund Raise 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 May 2026 17:33 IST NSE

Financial Results

Saroja Pharma Industries India H2 FY26 Results: Net Profit ₹1 Cr, Up 42.9% YoY

Saroja Pharma Industries India Ltd reported revenue from operations of ₹31.8 Cr (-9.1% YoY) and net profit of ₹1 Cr (+42.9% YoY) for H2 FY26.

Key figure: Net profit ₹1 Cr · +42.9% YoY

Open full results → Read the filing ↗

30 May 2026 17:32 IST NSE

Financial Results

Saroja Pharma Industries India Financial Results

Saroja Pharma approved its FY2026 audited financial results, reporting an annual total income of ₹70.24 Crore. The board confirmed an unmodified auditor's opinion on these standalone figures.

Value: ₹70.24 Cr

Read the filing ↗